5/31
11:19 am
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $3.00 price target on the stock.
Medium
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $3.00 price target on the stock.
5/29
08:00 am
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
Medium
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
5/28
07:20 am
uncy
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress [Yahoo! Finance]
High
Report
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress [Yahoo! Finance]
5/28
07:03 am
uncy
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
High
Report
Unicycive Therapeutics Delivers Multiple Presentations on Oxylanthanum Carbonate (OLC) and UNI-494 at the European Renal Association Congress
5/23
07:03 am
uncy
Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference
Medium
Report
Unicycive Therapeutics to Participate in a Fireside Chat at the Lytham Partners Spring 2024 Investor Conference
5/15
07:12 am
uncy
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting [Yahoo! Finance]
Low
Report
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting [Yahoo! Finance]
5/15
07:03 am
uncy
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting
Low
Report
Unicycive Therapeutics Presents Bioequivalence Data on Oxylanthanum Carbonate (OLC) at the National Kidney Foundation Spring Clinical Meeting
5/14
12:35 pm
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
Low
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
5/13
04:34 pm
uncy
Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
5/13
04:16 pm
uncy
Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update
Neutral
Report
Unicycive Announces First Quarter 2024 Financial Results and Provides Business Update
4/15
11:04 am
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $3.00 price target on the stock.
Low
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "speculative buy" rating re-affirmed by analysts at Benchmark Co.. They now have a $3.00 price target on the stock.
4/10
07:10 am
uncy
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference [Yahoo! Finance]
Low
Report
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference [Yahoo! Finance]
4/10
07:03 am
uncy
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
Low
Report
Unicycive Therapeutics to Present at the Noble Capital Markets Emerging Growth Virtual Healthcare Equity Conference
4/4
08:03 am
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $9.00 price target on the stock.
Low
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) is now covered by analysts at Piper Sandler. They set an "overweight" rating and a $9.00 price target on the stock.
4/1
08:09 am
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
Low
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
3/28
04:35 pm
uncy
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
Low
Report
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update [Yahoo! Finance]
3/28
04:15 pm
uncy
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
Low
Report
Unicycive Therapeutics Announces Full Year 2023 Financial Results and Provides Business Update
3/25
07:09 am
uncy
Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress [Yahoo! Finance]
Medium
Report
Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress [Yahoo! Finance]
3/25
07:03 am
uncy
Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress
Medium
Report
Unicycive Therapeutics to be Featured in Multiple Presentations at the Upcoming European Renal Association Congress
3/18
03:10 pm
uncy
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
Low
Report
Unicycive Therapeutics, Inc. (NASDAQ: UNCY) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $4.50 price target on the stock.
3/14
07:06 am
uncy
Unicycive Announces $50 Million Private Placement [Yahoo! Finance]
High
Report
Unicycive Announces $50 Million Private Placement [Yahoo! Finance]
3/14
07:03 am
uncy
Unicycive Announces $50 Million Private Placement
Low
Report
Unicycive Announces $50 Million Private Placement
3/13
07:03 am
uncy
Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference
Medium
Report
Unicycive Therapeutics Delivers Both an Oral and Poster Presentation on UNI-494 at the AKI and CRRT Conference
3/7
04:23 pm
uncy
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) [Yahoo! Finance]
Medium
Report
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC) [Yahoo! Finance]
3/7
04:12 pm
uncy
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)
Low
Report
Unicycive Therapeutics Completes Enrollment in Pivotal Clinical Trial for Oxylanthanum Carbonate (OLC)